EUVIMEDEUVIMED entdecken
Crossref

Novel oncogenic transcriptional targets of mutant p53 in esophageal squamous cell carcinoma

Sara A George iD, Viswakalyan Kotapalli, Pandilla Ramaswamy, Raju Kumar, Swarnalata Gowrishankar, Shantveer G Uppin, Murali D Bashyam iD

Journal of Cellular Biochemistry · 2024-04 · 125 (4)

DOI: 10.1002/jcb.30534 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular Biochemistry, online erschienen am 15.02.2024. Verfasst von Sara A George und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Oncology, Centre for DNA Fingerprinting and Diagnostics, Hyderabad, Telangana, India. Hauptthemen laut MEDLINE: Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms, Carcinoma, Squamous Cell. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Indian Council of Medical Research, Council of Scientific and Industrial Research, India, Department of Biotechnology, Ministry of Science and Technology, India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Missense mutations in the DNA binding domain of p53 are observed frequently in esophageal squamous cell carcinoma (ESCC). Recent studies have revealed the potentially oncogenic transcriptional networks regulated by mutant p53 proteins. However, majority of these studies have focused on common “hotspot” p53 mutations while rarer mutations are poorly characterized. In this study, we report the characterization of rare, “non‐hotspot” p53 mutations from ESCC. In vitro tumorigenic assays performed following ectopic‐expression of certain “non‐hotspot” mutant p53 proteins caused enhancement of oncogenic properties in squamous carcinoma cell lines. Genome‐wide transcript profiling of ESCC tumor samples stratified for p53 status, revealed several genes exhibiting elevated transcript levels in tumors harboring mutant p53. Of these, ARF6 , C1QBP , and TRIM23 were studied further. Reverse transcription‐quantitative PCR (RT‐qPCR) performed on RNA isolated from ESCC tumors revealed significant correlation of TP53 transcript levels with those of the three target genes. Ectopic expression of wild‐type and several mutant p53 forms followed by RT‐qPCR, chromatin affinity‐purification (ChAP), and promoter‐luciferase assays indicated the exclusive recruitment of p53 mutants—P190T and P278L, to the target genes leading to the activation of expression. Several functional assays following knockdown of the target genes revealed a significant suppression of tumorigenicity in squamous carcinoma cell lines. Rescue experiments confirmed the specificity of the knockdown. The tumorigenic effects of the genes were confirmed in nude mice xenograft assays. This study has therefore identified novel oncogenic targets of “non‐hotspot” mutant p53 proteins relevant for ESCC besides validating the functional heterogeneity of the spectrum of tumor‐specific p53 mutations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Esophageal Squamous Cell CarcinomaEsophageal NeoplasmsCarcinoma, Squamous CellAnimalsMiceHumansTumor Suppressor Protein p53Mice, NudeCell Line, TumorGene Expression Regulation, NeoplasticCell ProliferationGTP-Binding ProteinsCarrier ProteinsMitochondrial Proteins

Stichwörter der Autor:innen

ARF6C1QBPESCCTRIM23mutant p53

Substanzen

Tumor Suppressor Protein p53TRIM23 protein, humanGTP-Binding ProteinsC1QBP protein, humanCarrier ProteinsMitochondrial Proteins

Autor:innen und Institutionen

  • Laboratory of Molecular Oncology, Centre for DNA Fingerprinting and Diagnostics, Hyderabad, Telangana, India.
  • Graduate Studies, Regional Centre for Biotechnology, Faridabad, Haryana, India.
  • Graduate Studies, Manipal Academy of Higher Education, Manipal, Karnataka, India.
  • Apollo Hospitals, Hyderabad, Telangana, India.
  • Nizam's Institute of Medical Sciences, Hyderabad, Telangana, India.

ORCID-Profile: Sara A George, Murali D Bashyam

Förderung

  • Indian Council of Medical Research
  • Council of Scientific and Industrial Research, India
  • Department of Biotechnology, Ministry of Science and Technology, India

Zitieren

APA

George, S. A., Kotapalli, V., Ramaswamy, P., Kumar, R., Gowrishankar, S., Uppin, S. G., & Bashyam, M. D. (2024). Novel oncogenic transcriptional targets of mutant p53 in esophageal squamous cell carcinoma. Journal of Cellular Biochemistry, 125(4). https://doi.org/10.1002/jcb.30534

Vancouver

George SA, Kotapalli V, Ramaswamy P, Kumar R, Gowrishankar S, Uppin SG, et al. Novel oncogenic transcriptional targets of mutant p53 in esophageal squamous cell carcinoma. Journal of Cellular Biochemistry. 2024;125(4). doi:10.1002/jcb.30534

BibTeX
@article{George2024,
  author = {George, Sara A and Kotapalli, Viswakalyan and Ramaswamy, Pandilla and Kumar, Raju and Gowrishankar, Swarnalata and Uppin, Shantveer G and Bashyam, Murali D},
  title = {Novel oncogenic transcriptional targets of mutant p53 in esophageal squamous cell carcinoma},
  journal = {Journal of Cellular Biochemistry},
  year = {2024},
  volume = {125},
  number = {4},
  doi = {10.1002/jcb.30534}
}
Kostenlos starten →